Form 4: Centene Corp Director Wayne S. DeVeydt Reports Acquisition of Shares and Stock Options

Director Wayne S. DeVeydt of Centene Corp. reported acquiring 538 shares of common stock and stock options for 10,000 shares on December 31, 2024.

Summary

• Wayne S. DeVeydt, a director at Centene Corp, filed a Form 4 disclosing a transaction on December 31, 2024.
• The transaction involved the acquisition of 538 shares of common stock at a price of $0.
• Additionally, Mr. DeVeydt acquired stock options for 10,000 shares of common stock with an exercise price of $80.57, exercisable from February 7, 2025, and expiring on February 7, 2032.
• Following the transaction, Mr. DeVeydt directly owns 14,801.274 shares of common stock, which includes 2,916 restricted stock units subject to vesting requirements.

Sentiment

Score: 6

Explanation: The sentiment is neutral as it is a standard disclosure of insider transactions. The acquisition of shares and options could be seen as a positive sign, but it's not a major event.

Positives

• The acquisition of shares and stock options by a director could be seen as a positive sign of confidence in the company's future performance.

Industry Context

This filing is a routine disclosure of insider transactions, which is common in the healthcare industry where stock-based compensation is often used.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies, including Centene Corp, and are comparable to similar filings by directors and officers at other healthcare companies such as UnitedHealth Group (UNH) and CVS Health (CVS).
• The acquisition of stock options is a common form of executive compensation, and the terms of these options are similar to those seen in other companies in the sector.
• The vesting requirements for the restricted stock units are also typical for executive compensation packages.

Stakeholder Impact

• The transaction may have a minor positive impact on shareholder sentiment due to the director's increased stake in the company.

Key Dates

Keywords

Centene Corp, Director, Form 4, Stock Options, Share Acquisition, Wayne S. DeVeydt, Insider Trading